• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡铂脂质体(CPL)在免疫缺陷小鼠中的应用:对乳腺癌抗肿瘤活性的改善及造血刺激作用

Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.

作者信息

Fichtner I, Reszka R, Goan S R, Naundorf H

机构信息

Max-Delbrück-Center of Molecular Medicine, Berlin, Germany.

出版信息

Med Oncol. 1994;11(3-4):111-9. doi: 10.1007/BF02999858.

DOI:10.1007/BF02999858
PMID:7633830
Abstract

Carboplatin-liposomes (CPL) have been shown to possess a strong stimulatory activity on the hematopoiesis in immunocompetent mice. As we were interested in studying this pharmacological characteristic in parallel with any antitumour effects which might be expected for the encapsulated cytostatic, we used a panel of six human breast carcinomas xenotransplanted to nude mice. The antitumor activity as well as the hematopoietic effects of the vesicles were studied in comparison to, and in combination with, the free drug. Carboplatin was encapsulated into reverse phase evaporation vesicles (REV) and injected i.p. as a single dose of 75 mg kg-1 into tumor-free and breast-carcinoma-bearing animals, respectively. Following a single application of CPL in nude mice, a significant increase of the WBC numbers to about three times for that of the normal level could be observed over a period of at least 28 days. The elevation was due to an increase in both circulating granulocytes and lymphocytes. The peripheral effect was accompanied by a relative decrease of spleen cellularity, while the number of bone marrow cells was hardly affected. There was no influence detectable on circulating blood cells in SCID mice. However, a rather high toxicity of CPL for this immunodeficient mouse strain was noticed. In the panel of breast carcinomas used, free carboplatin and CPL displayed a different pattern of therapeutic efficiencies. In four of the five tumor models tested, a combination of the free with the liposomal drug showed a significant inhibition of tumor growth while effectively preventing a drug-induced leukopenia.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

卡铂脂质体(CPL)已被证明对免疫活性小鼠的造血功能具有强烈的刺激活性。由于我们有兴趣研究这种药理学特性以及包封的细胞抑制剂可能预期的任何抗肿瘤作用,我们使用了一组移植到裸鼠体内的六种人类乳腺癌。与游离药物相比并结合使用,研究了囊泡的抗肿瘤活性以及造血作用。将卡铂包封到反相蒸发囊泡(REV)中,分别以75 mg kg-1的单剂量腹腔注射到无肿瘤和患有乳腺癌的动物体内。在裸鼠单次应用CPL后,在至少28天的时间内,可以观察到白细胞数量显著增加至正常水平的约三倍。这种升高是由于循环粒细胞和淋巴细胞均增加所致。外周效应伴随着脾脏细胞数量的相对减少,而骨髓细胞数量几乎未受影响。在SCID小鼠中未检测到对循环血细胞的影响。然而,注意到CPL对这种免疫缺陷小鼠品系具有相当高的毒性。在所使用的乳腺癌组中,游离卡铂和CPL表现出不同的治疗效率模式。在测试的五个肿瘤模型中的四个中,游离药物与脂质体药物的组合显示出对肿瘤生长的显著抑制,同时有效地防止了药物诱导的白细胞减少。(摘要截断于250字)

相似文献

1
Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.卡铂脂质体(CPL)在免疫缺陷小鼠中的应用:对乳腺癌抗肿瘤活性的改善及造血刺激作用
Med Oncol. 1994;11(3-4):111-9. doi: 10.1007/BF02999858.
2
Carboplatin-liposomes as activators of hematopoiesis.卡铂脂质体作为造血激活剂。
Oncol Res. 1993;5(2):65-74.
3
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
Cancer Chemother Pharmacol. 1990;27(1):13-9. doi: 10.1007/BF00689270.
4
Pre- and postirradiation hemopoietic effects of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) administered to C57Bl/6 mice before irradiation.
Neoplasma. 1993;40(6):379-85.
5
Tumor inhibition and hematopoietic stimulation in mice by a synthetic copper-ATP complex.一种合成铜 - ATP 复合物对小鼠的肿瘤抑制和造血刺激作用。
Anticancer Drugs. 1993 Aug;4(4):505-10. doi: 10.1097/00001813-199308000-00013.
6
Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.米托蒽醌掺入单层脂质体的特性评估及其药代动力学性质、急性毒性和抗肿瘤疗效分析。
Cancer Chemother Pharmacol. 1991;27(6):429-39. doi: 10.1007/BF00685156.
7
Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft.叶酸受体靶向脂质体卡铂在局部治疗腹腔内生长的人卵巢肿瘤异种移植物中的有效治疗活性。
Int J Nanomedicine. 2012;7:739-51. doi: 10.2147/IJN.S26172. Epub 2012 Feb 14.
8
Hematologic effects of a single dose of methylnitrosourea.单剂量甲基亚硝基脲的血液学效应。
Exp Hematol. 1977 Jan;5(1):19-26.
9
Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice.
Eur J Cancer. 1994;30A(2):183-7. doi: 10.1016/0959-8049(94)90084-1.
10
Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.造血功能对环磷酰胺的反应在骨髓和脾脏中呈现出高度特异性的模式。
J Hematother Stem Cell Res. 2003 Feb;12(1):47-61. doi: 10.1089/152581603321210136.

引用本文的文献

1
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.脂质体在癌症治疗中的应用:我们从何出发,又身在何处。
Int J Mol Sci. 2023 Apr 1;24(7):6615. doi: 10.3390/ijms24076615.
2
Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft.叶酸受体靶向脂质体卡铂在局部治疗腹腔内生长的人卵巢肿瘤异种移植物中的有效治疗活性。
Int J Nanomedicine. 2012;7:739-51. doi: 10.2147/IJN.S26172. Epub 2012 Feb 14.

本文引用的文献

1
Carboplatin-liposomes as activators of hematopoiesis.卡铂脂质体作为造血激活剂。
Oncol Res. 1993;5(2):65-74.
2
Haemopoietic stem cells and progenitors of functional T-lymphocytes in the bone marrow of 'nude' mice.“裸”鼠骨髓中的造血干细胞和功能性T淋巴细胞祖细胞。
Clin Exp Immunol. 1973 Aug;14(4):597-607.
3
[A new infinite cell line, MaTu, of human mammary tumor-cells (author's transl)].
Arch Geschwulstforsch. 1974;44(1):1-10.
4
Observations on the immunobiology of 'nude' mice.关于“裸”鼠免疫生物学的观察
Immunology. 1971 Feb;20(2):247-52.
5
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.注射纯化重组小鼠粒细胞-巨噬细胞集落刺激因子的小鼠的造血反应。
Exp Hematol. 1987 Jan;15(1):1-9.
6
Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.卡铂概述:取代、补充并拓展顺铂的治疗领域
Semin Oncol. 1989 Apr;16(2 Suppl 5):7-13.
7
T cell receptor-independent cell-mediated cytotoxicity by nude mouse lymphokine-activated killer cells.裸鼠淋巴因子激活的杀伤细胞的非T细胞受体依赖性细胞介导的细胞毒性作用。
Jpn J Cancer Res. 1991 Apr;82(4):448-55. doi: 10.1111/j.1349-7006.1991.tb01869.x.
8
Carboplatin: an active drug in metastatic breast cancer.
J Clin Oncol. 1992 Mar;10(3):433-7. doi: 10.1200/JCO.1992.10.3.433.
9
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102.
10
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.异环磷酰胺、卡铂和依托泊苷联合用于诱导化疗和大剂量化疗:聚焦于乳腺癌和淋巴瘤。
Hematol Oncol. 1992 Jan-Feb;10(1):61-74. doi: 10.1002/hon.2900100111.